Skip to content

Early Exposure to OMT Prevents Long LOS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01784835
Enrollment
113
Registered
2013-02-06
Start date
2010-10-31
Completion date
2012-07-31
Last updated
2013-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prematurity

Keywords

Osteopathic manipulative treatment, neonatology, neonatal care, prematurity, complementary and alternative medicine, length of stay

Brief summary

The application of osteopathic manipulative treatment (OMT) in preterm infants has been demonstrated to be effective in reducing length of stay (LOS). The scope of the present study is to investigate the association between earlier exposure to OMT and reduction of LOS in premature infants

Interventions

OTHERosteopathic manipulative treatment

Patients from this group received osteopathic treatments twice a week for the entire length of stay in the unit.

OTHERUsual care

Patients from control group received standard care plus osteopathic evaluation only, according to the same schedule as the study group.

Sponsors

European Institute for Evidence Based Osteopathic Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
32 Weeks to 37 Weeks
Healthy volunteers
Yes

Inclusion criteria

* preterm infants born at age between 29 and 37 weeks * osteopathic treatment performed \< 14 days after birth * preterms born in the same hospital

Exclusion criteria

* Gestational age \< 29 weeks * Gestational age \> 37 weeks * First OMT performed after 14 days from birth * genetic disorders * congenital disorders * cardiovascular abnormalities * proven or suspected necrotized enterocolitis with or without gastrointestinal perforation proven or suspected abdominal obstruction * pre/post surgery patients * pneumoperitoneum * atelectasis * Newborn from an HIV seropositive/drug addicted mother * respiratory disorders * transferred to/from other hospital * admitted for preterminal comfort care (defined as neither intubation nor cardio-respiratory resuscitation)

Design outcomes

Primary

MeasureTime frame
Number of days of LOSparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks

Secondary

MeasureTime frame
effectiveness of OMT considering different lag time between birth and the first OMTparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026